Mohamed Elbadry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohamed Elbadry has a total of 234 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed El-Kassas
Endemic Medicine Department, Faculty of Medicine Capital University (Formerly Helwan University) Cairo Egypt
10 shared publications Marwa Tahoon
Epidemiology and Preventive Medicine Department, National Liver Institute, Menoufia University, Menoufia, Egypt
4 shared publications- Noha Eltaweel
Department of Medical Molecular Genetics, National Research Centre, Cairo, Egypt
4 shared publications Asmaa Bakr
Department of Hepato-Gastroenterology and Infectious Diseases, Al-Azhar University, Cairo, Egypt
3 shared publications- Dalia Omran
Endemic Medicine and Hepato-gastroenterology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
3 shared publications Gamal Esmat
3 shared publications
Latest Publications
- 2 September 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 418
Optic nerve sheath diameter by ocular ultrasonography rapidly detects high intracranial pressure in acute meningitis
- 2 September 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 418
Optic nerve sheath diameter by ocular ultrasonography rapidly detects high intracranial pressure in acute meningitis
- Open Access
- 25 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 23226
Clinico-demographic and molecular characteristics of familial Mediterranean fever in Egypt: a multicenter study
Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disease characterized by recurrent episodes of fever and serositis caused by mutations in the MEFV gene. FMF primarily affects individuals of Mediterranean ancestry. Typical manifestations include short-lasting attacks of abdominal pain, chest pain, and arthritis. Long-term complications, such as amyloidosis, might be prevented with colchicine treatment. This study aimed to assess the clinical, demographic and molecular features of FMF in Egyptian patients. This multicenter prospective study included 280 clinically suspected FMF patients referred to the outpatient clinics of participating centers. Patients were enrolled based on recurrent episodes of fever and abdominal pain suggestive of FMF. The diagnosis of FMF was established based on the Eurofever/PRINTO criteria, in addition to molecular genetic confirmation of MEFV mutations. Patients who did not meet diagnostic criteria were excluded. The study included 173 female patients, and 107 male patients with age range from 2 up to 60 years. All patients were descending from different families. Parental consanguinity was found in 24.6% while positive family history was seen in 33.2%. The duration of the attack in almost two third of the patients was less than 48 h, only 6% of the patients suffered attacks longer than 72 h. About half the patients achieved a marked reduction or complete cessation of FMF attacks, along with normalization or significant reduction of inflammatory markers (e.g., serum amyloid A), following colchicine therapy at a daily dose of 1.5–3 mg., only 6% needed higher doses. The initial serum amyloid A was normal in 47.5% in the patients and elevated in the remaining patients. Fever was documented in only 19.6% of patients at presentation; abdominal pain was among the most common presentation, seen in 62.1%. The most frequently observed MEFV allele was E148Q (143, 39.5%) followed by M694I ( n = 59, 16.3%), A744S and V726A ( n = 44, 12.2% for each), then M680I ( n = 35, 9.7%). In our multicenter study focused on Egyptians, 93.6% of the enrolled FMF patients carried at least one MEFV variant. The E148Q allele was the most frequently observed followed by M694I. The study also revealed that Egyptian patients exhibited a mild form of the disease with a female predominance. This mild presentation might be attributed to the high E148Q prevalence and low rate of amyloidosis in our cohort.
- 25 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 23226
Open AccessClinico-demographic and molecular characteristics of familial Mediterranean fever in Egypt: a multicenter study
Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disease characterized by recurrent episodes of fever and serositis caused by mutations in the MEFV gene. FMF primarily affects individuals of Mediterranean ancestry. Typical manifestations include short-lasting attacks of abdominal pain, chest pain, and arthritis. Long-term complications, such as amyloidosis, might be prevented with colchicine treatment. This study aimed to assess the clinical, demographic and molecular features of FMF in Egyptian patients. This multicenter prospective study included 280 clinically suspected FMF patients referred to the outpatient clinics of participating centers. Patients were enrolled based on recurrent episodes of fever and abdominal pain suggestive of FMF. The diagnosis of FMF was established based on the Eurofever/PRINTO criteria, in addition to molecular genetic confirmation of MEFV mutations. Patients who did not meet diagnostic criteria were excluded. The study included 173 female patients, and 107 male patients with age range from 2 up to 60 years. All patients were descending from different families. Parental consanguinity was found in 24.6% while positive family history was seen in 33.2%. The duration of the attack in almost two third of the patients was less than 48 h, only 6% of the patients suffered attacks longer than 72 h. About half the patients achieved a marked reduction or complete cessation of FMF attacks, along with normalization or significant reduction of inflammatory markers (e.g., serum amyloid A), following colchicine therapy at a daily dose of 1.5–3 mg., only 6% needed higher doses. The initial serum amyloid A was normal in 47.5% in the patients and elevated in the remaining patients. Fever was documented in only 19.6% of patients at presentation; abdominal pain was among the most common presentation, seen in 62.1%. The most frequently observed MEFV allele was E148Q (143, 39.5%) followed by M694I ( n = 59, 16.3%), A744S and V726A ( n = 44, 12.2% for each), then M680I ( n = 35, 9.7%). In our multicenter study focused on Egyptians, 93.6% of the enrolled FMF patients carried at least one MEFV variant. The E148Q allele was the most frequently observed followed by M694I. The study also revealed that Egyptian patients exhibited a mild form of the disease with a female predominance. This mild presentation might be attributed to the high E148Q prevalence and low rate of amyloidosis in our cohort.
- 22 May 2026
- Published by Elsevier
- p. 3-24
Hepatitis C virus: Overview
- 22 May 2026
- Published by Elsevier
Contributors
- Open Access
- 10 July 2025
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 6, 1001344
Burden, risks, and management recommendations for hepatitis B in healthcare workers worldwide with a special focus on Africa
Hepatitis B virus (HBV) infection is an important global public issue with several routes of transmission. HBV infection among healthcare workers (HCWs) is of particular concern due to the high transmissibility of the virus compared with other bloodborne viruses, putting infected HCWs at risk of transmitting HBV to patients. These considerations necessitate the implementation of standard recommendations for preventing and managing HBV in HCWs. Over the past four decades, the incidence of HBV transmission from HCWs to patients has significantly decreased in frequency, and this could be due to enhanced screening, routine vaccination of HCWs, and following general precautions such as double-gloving during exposure-prone procedures. The protocols for monitoring infected HCWs differ based on the guidelines provided by health authorities.
- 10 July 2025
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 6, 1001344
Open AccessBurden, risks, and management recommendations for hepatitis B in healthcare workers worldwide with a special focus on Africa
Hepatitis B virus (HBV) infection is an important global public issue with several routes of transmission. HBV infection among healthcare workers (HCWs) is of particular concern due to the high transmissibility of the virus compared with other bloodborne viruses, putting infected HCWs at risk of transmitting HBV to patients. These considerations necessitate the implementation of standard recommendations for preventing and managing HBV in HCWs. Over the past four decades, the incidence of HBV transmission from HCWs to patients has significantly decreased in frequency, and this could be due to enhanced screening, routine vaccination of HCWs, and following general precautions such as double-gloving during exposure-prone procedures. The protocols for monitoring infected HCWs differ based on the guidelines provided by health authorities.
- Open Access
- 20 June 2025
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 45 (02) , e1-e6
Colonoscopic Findings of Patients with Rectal Bleeding: Insights from a Single Centre Study
Rectal bleeding is a common symptom prompting an urgent investigation. Colonoscopy plays a crucial role in diagnosing the underlying cause and guiding treatment. We aimed to analyze colonoscopic findings in patients with rectal bleeding at a single center.A retrospective review was conducted on the medical records of patients who underwent colonoscopy for suspected rectal bleeding. Data collected included demographics, clinical presentation, colonoscopic findings, and final diagnoses.A total of 205 patients underwent colonoscopy for rectal bleeding. The mean age was 47.35 ± 14.6 years, with a male predominance of 57.5%. Hematochezia was the most common presentation (73%), followed by melena (18%) and maroon stools (9%). Colonoscopy identified 5 different sources of bleeding. Hemorrhoids were the most common endoscopic finding (76%), followed by combined hemorrhoids and colonic polyps (38%), colonic polyps alone (28%), and colorectal cancer (20%). No lesions were detected in 10% of patients. The left colon emerged as the most frequent site for bleeding lesions (88.1%). Age influenced the distribution of endoscopic findings. Hemorrhoids were prevalent in both age groups, but the presence of both hemorrhoids and polyps/masses was more frequent in younger patients (<45 years). Rectal ulcers were observed exclusively in younger patients, while CRC showed a slightly higher prevalence in this group.Hemorrhoids are the leading cause of LGIB in Upper Egypt, with a higher prevalence compared to other regions. The left colon was the common location for bleeding lesions. Age may influence the causes of LGIB, younger patients present more frequently with combined pathologies.
- 20 June 2025
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 45 (02) , e1-e6
Open AccessColonoscopic Findings of Patients with Rectal Bleeding: Insights from a Single Centre Study
Rectal bleeding is a common symptom prompting an urgent investigation. Colonoscopy plays a crucial role in diagnosing the underlying cause and guiding treatment. We aimed to analyze colonoscopic findings in patients with rectal bleeding at a single center.A retrospective review was conducted on the medical records of patients who underwent colonoscopy for suspected rectal bleeding. Data collected included demographics, clinical presentation, colonoscopic findings, and final diagnoses.A total of 205 patients underwent colonoscopy for rectal bleeding. The mean age was 47.35 ± 14.6 years, with a male predominance of 57.5%. Hematochezia was the most common presentation (73%), followed by melena (18%) and maroon stools (9%). Colonoscopy identified 5 different sources of bleeding. Hemorrhoids were the most common endoscopic finding (76%), followed by combined hemorrhoids and colonic polyps (38%), colonic polyps alone (28%), and colorectal cancer (20%). No lesions were detected in 10% of patients. The left colon emerged as the most frequent site for bleeding lesions (88.1%). Age influenced the distribution of endoscopic findings. Hemorrhoids were prevalent in both age groups, but the presence of both hemorrhoids and polyps/masses was more frequent in younger patients (<45 years). Rectal ulcers were observed exclusively in younger patients, while CRC showed a slightly higher prevalence in this group.Hemorrhoids are the leading cause of LGIB in Upper Egypt, with a higher prevalence compared to other regions. The left colon was the common location for bleeding lesions. Age may influence the causes of LGIB, younger patients present more frequently with combined pathologies.
- Open Access
- 19 June 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (7)
Letter to the Editor: Examining pregnancy outcomes in alcohol-associated hepatitis: A call for further research
- 19 June 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (7)
Open AccessLetter to the Editor: Examining pregnancy outcomes in alcohol-associated hepatitis: A call for further research
- 23 May 2025
- Published by Wiley in Liver International
- Vol. 45 (6) , e70108
Metabolic Dysfunction‐Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda
Background & Aims: Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing health challenge, particularly in Middle East and North Africa (MENA) countries. This study aimed to establish a consensus‐driven research and action agenda to address MASLD within the MENA region.Methods: Following a global MASLD research and action agenda setting study, over two Delphi rounds (Rs), MENA region experts (R1 n = 112, R2 n = 104) indicated their level of agreement with and provided feedback on MASLD research and action priorities via Qualtrics XM. In R2, panellists also ranked the priorities, which were categorised across six domains: (1) the human and economic burden, (2) defining and implementing care models, (3) disease management, (4) education and awareness, (5) patient and community perspectives, and (6) leadership and policies for the MASLD public health agenda.Results: The consensus‐built MASLD research and action priority agenda for the MENA region comprises 52 priorities. Combined agreement (i.e., ‘agree’ + ‘somewhat agree’) increased from 97.6% and 98.1% in R1 to 98.2% and 98.5% in R2 with the research (n = 30) and action (n = 22) priorities, respectively. The highest ranked research priorities included developing regional MASLD databases and validating non‐invasive diagnostic tools. The highest ranked action priorities included taking steps to enhance the adoption of lifestyle interventions among people living with MASLD and improving disease knowledge among healthcare providers.Conclusions: This region‐specific agenda can help to guide research and optimise clinical practice, thereby improving the understanding, prevention, and management of MASLD, enhancing health outcomes and reducing its burden within the MENA region.
- 23 May 2025
- Published by Wiley in Liver International
- Vol. 45 (6) , e70108
Metabolic Dysfunction‐Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda
Background & Aims: Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing health challenge, particularly in Middle East and North Africa (MENA) countries. This study aimed to establish a consensus‐driven research and action agenda to address MASLD within the MENA region.Methods: Following a global MASLD research and action agenda setting study, over two Delphi rounds (Rs), MENA region experts (R1 n = 112, R2 n = 104) indicated their level of agreement with and provided feedback on MASLD research and action priorities via Qualtrics XM. In R2, panellists also ranked the priorities, which were categorised across six domains: (1) the human and economic burden, (2) defining and implementing care models, (3) disease management, (4) education and awareness, (5) patient and community perspectives, and (6) leadership and policies for the MASLD public health agenda.Results: The consensus‐built MASLD research and action priority agenda for the MENA region comprises 52 priorities. Combined agreement (i.e., ‘agree’ + ‘somewhat agree’) increased from 97.6% and 98.1% in R1 to 98.2% and 98.5% in R2 with the research (n = 30) and action (n = 22) priorities, respectively. The highest ranked research priorities included developing regional MASLD databases and validating non‐invasive diagnostic tools. The highest ranked action priorities included taking steps to enhance the adoption of lifestyle interventions among people living with MASLD and improving disease knowledge among healthcare providers.Conclusions: This region‐specific agenda can help to guide research and optimise clinical practice, thereby improving the understanding, prevention, and management of MASLD, enhancing health outcomes and reducing its burden within the MENA region.
- Open Access
- 16 January 2025
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 37 (1) , 1-12
Management of acute bacterial meningitis in a limited resource setting: an Egyptian consensus model
Acute bacterial meningitis (ABM) is an emerging disease with high morbidity and mortality. It is a globally serious disease and is considered endemic in Egypt, affecting all age groups and being common in low-standard and overcrowded areas. Early and appropriate antimicrobial therapy is crucial for suspected bacterial meningitis, even before the causative pathogen is identified. This is because definitive laboratory confirmation can take several days and may not always be successful. Those who do recover, especially if there was delayed appropriate intervention, can have permanent disabilities, such as brain damage, hearing loss, and learning disabilities. Rapid intervention in such cases is mandatory, which is not easy in countries with limited income due to weak capabilities and resources. Therefore, we are in dire need of making an Egyptian consensus that suits our country as a low-resource one, in order to facilitate and speed up the process of managing such cases. This consensus-based paper is under the supervision of the Egyptian Society of Fever comprising clinicians, microbiologists, epidemiologists, and public health representatives. They convened to assess the current situation and develop a new consensus on the management of ABM, taking into consideration the human and health potential of Egypt. All the experts who participated in writing and directing this conference belong to different Egyptian universities, and their main clinical interest was infectious diseases. Others work in fever hospitals that are affiliated with the Ministry of Health. They collaborated on the statements` writing, reviewing, and voting to reach the final version. Each statement was voted as strongly, moderately, or weekly recommended. Each statement should have a predefined score of 80% agreement to be accepted and reported in this consensus. Conclusion This Egyptian consensus model offers a feasible and context-specific approach to managing ABM, aiming to improve outcomes and reduce disparities in resource-limited settings.
- 16 January 2025
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 37 (1) , 1-12
Open AccessManagement of acute bacterial meningitis in a limited resource setting: an Egyptian consensus model
Acute bacterial meningitis (ABM) is an emerging disease with high morbidity and mortality. It is a globally serious disease and is considered endemic in Egypt, affecting all age groups and being common in low-standard and overcrowded areas. Early and appropriate antimicrobial therapy is crucial for suspected bacterial meningitis, even before the causative pathogen is identified. This is because definitive laboratory confirmation can take several days and may not always be successful. Those who do recover, especially if there was delayed appropriate intervention, can have permanent disabilities, such as brain damage, hearing loss, and learning disabilities. Rapid intervention in such cases is mandatory, which is not easy in countries with limited income due to weak capabilities and resources. Therefore, we are in dire need of making an Egyptian consensus that suits our country as a low-resource one, in order to facilitate and speed up the process of managing such cases. This consensus-based paper is under the supervision of the Egyptian Society of Fever comprising clinicians, microbiologists, epidemiologists, and public health representatives. They convened to assess the current situation and develop a new consensus on the management of ABM, taking into consideration the human and health potential of Egypt. All the experts who participated in writing and directing this conference belong to different Egyptian universities, and their main clinical interest was infectious diseases. Others work in fever hospitals that are affiliated with the Ministry of Health. They collaborated on the statements` writing, reviewing, and voting to reach the final version. Each statement was voted as strongly, moderately, or weekly recommended. Each statement should have a predefined score of 80% agreement to be accepted and reported in this consensus. Conclusion This Egyptian consensus model offers a feasible and context-specific approach to managing ABM, aiming to improve outcomes and reduce disparities in resource-limited settings.
- Open Access
- 18 July 2024
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 14 (1) , 1-8
Covert hepatic encephalopathy: a neglected topic—a narrative review
Covert hepatic encephalopathy (CHE) is a form of cerebral dysfunction that affects 30–40% of patients with liver cirrhosis as a grave sequel of disease progression. Although being a silent condition, yet; CHE has been reported as seriously predictive for the development of overt hepatic encephalopathy. Covert hepatic encephalopathy is said to conclude grades (0 and 1) hepatic encephalopathy in West Heaven grading of hepatic encephalopathy, hence; inferring to discrete deficits in attention, cognition, and motor control, strongly associated with poorer quality of private and social aspects of the patients’ life. Clinical recognition of cases of CHE is such a tedious task that unluckily devoid of discernment. Worthwhile; the battery of neuropsychometric tests widely known as the only tool to identify CHE can give abnormal results without specifying the cause of brain dysfunction Therefore, dedicated history-taking and clinical evaluation of liver cirrhosis patients are still the cornerstones that should unify other diagnostic tools to identify those patients at risk of developing overt hepatic encephalopathy. Diagnosis of CHE is challenging and often neglected in clinical practice, so the aim of this review is to improve our approach to CHE and begin a unified effort for the advancement of CHE through studying easy, fast, and reliable psychometric diagnostic tests to meet our clinical needs.
- 18 July 2024
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 14 (1) , 1-8
Open AccessCovert hepatic encephalopathy: a neglected topic—a narrative review
Covert hepatic encephalopathy (CHE) is a form of cerebral dysfunction that affects 30–40% of patients with liver cirrhosis as a grave sequel of disease progression. Although being a silent condition, yet; CHE has been reported as seriously predictive for the development of overt hepatic encephalopathy. Covert hepatic encephalopathy is said to conclude grades (0 and 1) hepatic encephalopathy in West Heaven grading of hepatic encephalopathy, hence; inferring to discrete deficits in attention, cognition, and motor control, strongly associated with poorer quality of private and social aspects of the patients’ life. Clinical recognition of cases of CHE is such a tedious task that unluckily devoid of discernment. Worthwhile; the battery of neuropsychometric tests widely known as the only tool to identify CHE can give abnormal results without specifying the cause of brain dysfunction Therefore, dedicated history-taking and clinical evaluation of liver cirrhosis patients are still the cornerstones that should unify other diagnostic tools to identify those patients at risk of developing overt hepatic encephalopathy. Diagnosis of CHE is challenging and often neglected in clinical practice, so the aim of this review is to improve our approach to CHE and begin a unified effort for the advancement of CHE through studying easy, fast, and reliable psychometric diagnostic tests to meet our clinical needs.